Previous 10 | Next 10 |
FinancialBuzz.com News Commentary New York, NY (11/19/2020) – Recent reports from across the country clearly show that infection cases are once again surging. More than 11.4 million Americans have now been infected with the virus and the number of deaths has surpassed 248,000. In...
Shares of Co-Diagnostics (NASDAQ: CODX) were getting clobbered on Tuesday, with the stock down 15.9% as of 12:02 p.m. EST. The decline resulted from the molecular diagnostics company's third-quarter update, provided after the market closed on Monday. Although Co-Diagnostics reported...
Gainers: Lexicon Pharmaceuticals (LXRX) +45%, Zomedica Pharmaceuticals (ZOM) +33%, Miragen Therapeutics (MGEN) +17%, SQZ Biotechnologies (SQZ) +15%, PLx Pharma (PLXP) +13%.Losers: Brainstorm Cell Therapeutics (BCLI) -67%, GoodRx Holdings (GDRX) ...
Brainstorm Cell Therapeutics (BCLI) -69% after announcing topline results from Phase 3 trial evaluating NurOwn.Alterity Therapeutics (ATHE) -24%.iBio (IBIO) -20% on FQ1 earnings release.The Alkaline Water Company (WTER) -17% on FQ2 earnings release.GoodRx Holding...
Co-Diagnostics (CODX) announces that its Logix Smart ABC (Influenza A/B, SARS-CoV-2) and its Logix Smart SARS-CoV-2 (genes RdRp/E) multiplex tests have obtained regulatory authorization to be sold as in vitro diagnostics ((IVD)) for COVID-19 detection in markets accepting CE-markings. Both mu...
Co-Diagnostics, Inc. Receives CE Markings for "ABC" and SARS-CoV-2 2-Gene Multiplex Tests New tests expand global reach of Company COVID-19 test menu PR Newswire SALT LAKE CITY, Nov. 17, 2020 SALT LAKE CITY , Nov. 17, 2020 /PRNewswire/ -- Co-Diagnost...
Co-Diagnostics, Inc. (CODX) Q3 2020 Earnings Conference Call November 16, 2020, 16:30 ET Company Participants Dwight Egan - Chairman, CEO & President Reed Benson - CFO & Secretary Conference Call Participants Theodore O'Neill - Litchfield Hills Research Yi Chen - H.C. Wainwright &...
Co-Diagnostics (CODX): Q3 GAAP EPS of $0.53 misses by $0.10.Revenue of $21.82M misses by $10.98M.Stock -13.91% AHPress Release For further details see: Co-Diagnostics EPS misses by $0.10, misses on revenue
Co-Diagnostics, Inc. Announces Q3 2020 Financial Results Including YTD Net Income per Common Share of $1.07 Company also announces receipt of CE markings for both Logix Smart ABC and SARS-CoV-2 2-gene tests PR Newswire SALT LAKE CITY, Nov. 16, 2020 SALT LAKE CI...
Pyxis Tankers PXS -22% on Q3 earnings release.Casper Sleep CSPR -13% on Q3 earnings release.Hall of Fame Resort & Entertainment (HOFV) -12%.Nautilus (NLS) -10%.EuroDry (EDRY) -9%.Sino-Global Shipping America (SINO) -9%.Co-Diagnostics (CODX) -16%.BioNTech BNTX -8%&...
News, Short Squeeze, Breakout and More Instantly...
Co-Diagnostics, Inc. to Host Booth and Discuss Advancing POC/OTC Diagnostics at ADLM 2024 in Chicago PR Newswire SALT LAKE CITY , July 29, 2024 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company wi...
Co-Diagnostics, Inc. Announces Second Quarter 2024 Earnings Release Date and Webcast PR Newswire SALT LAKE CITY , July 25, 2024 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the developme...
Co-Diagnostics, Inc. Expands Vector Control Customer Base to 25 Customers across 15 U.S. States PR Newswire SALT LAKE CITY , July 2, 2024 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx™"), a molecular diagnostics company w...